scholarly article | Q13442814 |
meta-analysis | Q815382 |
P50 | author | Henrik Hagberg | Q37370618 |
P2093 | author name string | Lin Ma | |
Sidhartha Tan | |||
Zhongjie Shi | |||
Kehuan Luo | |||
Sanjay Chawla | |||
Girija Natarajan | |||
Monika Bajaj | |||
P2860 | cites work | Forest plots: trying to see the wood and the trees | Q24525229 |
Risk factors for cerebral palsy in preterm infants | Q46527833 | ||
Placental lesions as predictors of cerebral palsy and abnormal neurocognitive function at school age in extremely low birth weight infants (<1 kg). | Q47279472 | ||
Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants | Q47281085 | ||
Prenatal events and the risk of cerebral palsy in very low birth weight infants | Q47293581 | ||
Population cohort associating chorioamnionitis, cord inflammatory cytokines and neurologic outcome in very preterm, extremely low birth weight infants | Q47348865 | ||
Histological chorioamnionitis is associated with cerebral palsy in preterm neonates. | Q47644862 | ||
Prospective evaluation of perinatal risk factors for cerebral palsy and delayed development in high risk infants | Q48112783 | ||
Antecedents of cerebral palsy in a multicenter trial of indomethacin for intraventricular hemorrhage | Q48695535 | ||
Prevalence of cerebral palsy: Autism and Developmental Disabilities Monitoring Network, three sites, United States, 2004. | Q50344331 | ||
Chorioamnionitis and outcome in extremely preterm infants. | Q50483054 | ||
Intrauterine infection, magnesium sulfate exposure and cerebral palsy in infants born between 26 and 30 weeks of gestation. | Q51394133 | ||
Effect of chorioamnionitis on neurodevelopmental outcome in preterm infants. | Q51924359 | ||
Antenatal steroids may reduce adverse neurological outcome following chorioamnionitis: neurodevelopmental outcome and chorioamnionitis in premature infants. | Q51931421 | ||
Intrauterine infection with Ureaplasma species is associated with adverse neuromotor outcome at 1 and 2 years adjusted age in preterm infants. | Q51947182 | ||
Risk factors for cerebral palsy in PPROM and preterm delivery with intact membranes (.). | Q53165592 | ||
Children who "outgrew' cerebral palsy | Q70355272 | ||
Cerebral palsy | Q72666334 | ||
Survival and neonatal and neurodevelopmental outcome of 24-29 week gestation infants according to primary cause of preterm delivery | Q73509190 | ||
Intrauterine infection and the risk of cerebral palsy in very low-birthweight infants | Q74246478 | ||
Maternal antecedents for cerebral palsy in extremely preterm babies: a case-control study | Q74551614 | ||
Does peripartum infection increase the incidence of cerebral palsy in extremely low birthweight infants? | Q80233404 | ||
Perinatal factors associated with the neurologic impairment of children born preterm | Q81013339 | ||
Cerebral palsy | Q89217011 | ||
Cerebral palsy and placental infection: a case-cohort study | Q24797190 | ||
Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting | Q27861077 | ||
Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis | Q28138808 | ||
Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis | Q28189245 | ||
The gut microbiota shapes intestinal immune responses during health and disease | Q29547727 | ||
Assessing heterogeneity in meta-analysis: Q statistic or I2 index? | Q29619545 | ||
Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. | Q33896064 | ||
Risk of cerebral palsy in relation to pregnancy disorders and preterm birth: a national cohort study | Q33934526 | ||
Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment--United States, 2003. | Q34293420 | ||
Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy | Q34434035 | ||
Chorioamnionitis and early childhood outcomes among extremely low-gestational-age neonates. | Q34449153 | ||
Prenatal Factors in Singletons with Cerebral Palsy Born at or near Term | Q34492064 | ||
Systematic review of chorioamnionitis and cerebral palsy | Q34580881 | ||
Health care use and health and functional impact of developmental disabilities among US children, 1997-2005. | Q34602674 | ||
Evaluation and Management of Women and Newborns With a Maternal Diagnosis of Chorioamnionitis: Summary of a Workshop | Q34675647 | ||
Correlation between initial neonatal and early childhood outcomes following preterm birth | Q34729090 | ||
Chorioamnionitis and cerebral palsy in term and near-term infants | Q35596413 | ||
Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance | Q36640880 | ||
Maternal Infections During Pregnancy and Cerebral Palsy in the Child. | Q36711767 | ||
Histological characteristics of the fetal inflammatory response associated with neurodevelopmental impairment and death in extremely preterm infants | Q37097791 | ||
Chorioamnionitis and cerebral palsy: a meta-analysis | Q37776130 | ||
Neonatal cytokines and cerebral palsy in very preterm infants | Q38453235 | ||
Onset factors in cerebral palsy: A systematic review. | Q38798495 | ||
Chorioamnionitis at birth does not increase the risk of neurodevelopmental disability in premature infants with bronchopulmonary dysplasia | Q39463263 | ||
Association of severe placental inflammation with death prior to discharge and cerebral palsy in preterm infants. | Q39591742 | ||
Maternal infection and risk of cerebral palsy in term and preterm infants | Q40521296 | ||
Cerebral palsy in preterm infants: a population-based case-control study of antenatal and intrapartal risk factors | Q40575178 | ||
Maternal Infection and Cerebral Palsy in Infants of Normal Birth Weight | Q40648005 | ||
Methods for exploring heterogeneity in meta-analysis | Q40689559 | ||
Term maternal and neonatal complications of acute chorioamnionitis | Q40816777 | ||
Perinatal correlates of cerebral palsy and other neurologic impairment among very low birth weight children. | Q40848735 | ||
Long-term outcomes of antenatal corticosteroids treatment in very preterm infants after chorioamnionitis | Q40922845 | ||
Cerebral palsy in very low birthweight infants | Q41199160 | ||
Clinical chorioamnionitis at term I: microbiology of the amniotic cavity using cultivation and molecular techniques | Q41462724 | ||
Impact of chorioamnionitis on short- and long-term outcomes in very low birth weight preterm infants: the Neonatal Research Network Japan | Q41611607 | ||
Prevalence of cerebral palsy in twins, triplets and quadruplets | Q43619127 | ||
The relationship between placental and other perinatal risk factors for neurologic impairment in very low birth weight children | Q44556351 | ||
The impact of clinical maternal chorioamnionitis on neurological and psychological sequelae in very-low-birth weight infants: a case-control study | Q44755512 | ||
Histological chorioamnionitis and neurodevelopmental outcome in preterm infants. | Q46011545 | ||
Effect of clinical and histological chorioamnionitis on the outcome of preterm infants | Q46323384 | ||
Prenatal and perinatal factors in the etiology of cerebral palsy | Q46388821 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cerebral palsy | Q210427 |
P577 | publication date | 2017-06-01 | |
P1433 | published in | Pediatrics | Q7159238 |
P1476 | title | Chorioamnionitis in the Development of Cerebral Palsy: A Meta-analysis and Systematic Review | |
P478 | volume | 139 |
Q47899520 | Chorioamnionitis, IL-17A, and fetal origins of neurologic disease |
Q98771393 | DNA Methylation Profile in Human Cord Blood Mononuclear Leukocytes From Term Neonates: Effects of Histological Chorioamnionitis |
Q90288012 | Histological chorioamnionitis and developmental outcomes in very preterm infants |
Q64234558 | Impact of different stages of intrauterine inflammation on outcome of preterm neonates: Gestational age-dependent and -independent effect |
Q92088498 | Is chorioamnionitis associated with neurodevelopmental outcomes in preterm infants? A systematic review and meta-analysis following PRISMA |
Q93132005 | Placental assessment provides insight into mechanisms and timing of neonatal hypoxic-ischemic encephalopathy |
Search more.